WHO ICTRP trial
A controlled study to evaluate the safety and efficacy of the study drug…
EUCTR2017-003021-15-PL · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2017-003021-15-PL |
|---|---|
| Public title | A controlled study to evaluate the safety and efficacy of the study drug, CCX140-B, in subjects with Focal Segmental Glomerulosclerosis (a type of glomerular disease) |
| Scientific title | A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects with Focal Segmental Glomerulosclerosis (FSGS) |
| Primary sponsor | ChemoCentryx, Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | France;United States;Czech Republic;Canada;Poland;Australia;Germany;New Zealand;Italy;United Kingdom |
| Conditions | Focal Segmental Glomerulosclerosis (FSGS) MedDRA version: 20.0 Level: PT Classification code 10067757 Term: Focal segmental glomerulosclerosis System Organ Class: 10038359 - Renal and urinary disorders ;Therapeutic area: Diseases [C]… |
| Interventions | Product Code: CCX140-B Pharmaceutical Form: Tablet INN or Proposed INN: INN not available yet Current Sponsor code: CCX140-B Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 5- Pharmaceutical form of the… |
| Registration date | May 18, 2018 |
| Target size | 40 |
| Secondary IDs | CL011_140;134007;2017-003021-15-FR |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: